PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
Chimax 250mg tablets
0803042H0BCAAAA
Chimax Flutamide Malignant Disease and Immunosuppression No data available
Chlorambucil 5mg tablets
0801010F0AAABAB
Chlorambucil Chlorambucil Malignant Disease and Immunosuppression No data available
Chlormethine 10mg solution for injection vials
0801010W0AAAAAA
Chlormethine hydrochloride Chlormethine hydrochloride Malignant Disease and Immunosuppression No data available
Chlormethine 160micrograms/g gel
0801010W0AAABAB
Chlormethine hydrochloride Chlormethine hydrochloride Malignant Disease and Immunosuppression No data available
Ciclosporin 250mg/5ml solution for infusion ampoules
0802020G0AAAEAE
Ciclosporin (Systemic) Ciclosporin Malignant Disease and Immunosuppression No data available
Ciclosporin 50mg/1ml solution for infusion ampoules
0802020G0AAAAAA
Ciclosporin (Systemic) Ciclosporin Malignant Disease and Immunosuppression No data available
Cisplatin 100mg/100ml solution for infusion vials
0801050I0AAAFAF
Cisplatin Cisplatin Malignant Disease and Immunosuppression No data available
Cisplatin 10mg/10ml solution for infusion vials
0801050I0AAAEAE
Cisplatin Cisplatin Malignant Disease and Immunosuppression No data available
Cisplatin 50mg powder for solution for infusion vials
0801050I0AAABAB
Cisplatin Cisplatin Malignant Disease and Immunosuppression No data available
Cisplatin 50mg/50ml solution for infusion vials
0801050I0AAADAD
Cisplatin Cisplatin Malignant Disease and Immunosuppression No data available
Cladribine 10mg tablets
0802040AYAAAAAA
Cladribine (Immunoglobulin) Cladribine (Immunomodulating) Malignant Disease and Immunosuppression No data available
Cladribine 10mg/10ml solution for infusion vials
0801030C0AAAAAA
Cladribine Cladribine Malignant Disease and Immunosuppression No data available
Cladribine 10mg/5ml solution for injection vials
0801030C0AAABAB
Cladribine Cladribine Malignant Disease and Immunosuppression No data available
Clofarabine 20mg/20ml solution for infusion vials
0801030AAAAAAAA
Clofarabine Clofarabine Malignant Disease and Immunosuppression No data available
Cobimetinib 20mg tablets
0801050CIAAAAAA
Cobimetinib Cobimetinib Malignant Disease and Immunosuppression No data available
Cometriq 20mg capsules
0801050BRBBAAAA
Cometriq Cabozantinib Malignant Disease and Immunosuppression No data available
Cometriq 20mg capsules and Cometriq 80mg capsules
0801050BRBBABAB
Cometriq Cabozantinib Malignant Disease and Immunosuppression No data available
Connaught strain BCG 81mg instil vials
0802040X0AAABAB
Bacillus Calmette-Guerin (B.C.G.) (Immunomodulator) Bacillus calmette-guerin (B.C.G.) Malignant Disease and Immunosuppression No data available
Copaxone 20mg inj vials
0802040U0BBAAAA
Copaxone Glatiramer acetate Malignant Disease and Immunosuppression No data available
Copaxone 20mg/1ml solution for injection pre-filled syringes
0802040U0BBABAB
Copaxone Glatiramer acetate Malignant Disease and Immunosuppression No data available
Copaxone 40mg/1ml solution for injection pre-filled syringes
0802040U0BBACAC
Copaxone Glatiramer acetate Malignant Disease and Immunosuppression No data available
Cosmegen Lyovac 500microgram inj vials
0801020D0BBAAAA
Cosmegen Lyovac Dactinomycin Malignant Disease and Immunosuppression No data available
Cotellic 20mg tablets
0801050CIBBAAAA
Cotellic Cobimetinib Malignant Disease and Immunosuppression No data available
Crisantaspase 10,000unit inj vials
0801050J0AAAAAA
Crisantaspase Crisantaspase Malignant Disease and Immunosuppression No data available
Cyclophosphamide 100mg/5ml oral liquid
0801010H0AAARAR
Cyclophosphamide Cyclophosphamide Malignant Disease and Immunosuppression No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.